| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/03/2006 | WO2004020455A3 Genes involved in neuropsychiatric disorders |
| 08/03/2006 | WO2004007746A3 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN |
| 08/03/2006 | WO2004007680A3 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing an adenosine kinase |
| 08/03/2006 | WO2004001381A8 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/03/2006 | WO2003014318A3 Methods for treating diabetes and other blood sugar disorders |
| 08/03/2006 | WO2003013425A3 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation |
| 08/03/2006 | WO2002102319A3 Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, bgs-8, expressed highly in immune tissue |
| 08/03/2006 | US20060174355 Method of screening drug |
| 08/03/2006 | US20060173637 Method of compensating for a measuring error and an electronic arrangement to this end |
| 08/03/2006 | US20060173580 Air quality monitoring systems and methods |
| 08/03/2006 | US20060173579 Air quality monitoring systems and methods |
| 08/03/2006 | US20060173380 Analysis apparatus and analysis method for body fluids |
| 08/03/2006 | US20060173256 Apparatus and method for controlling operation of vehicles or machinery by intoxicated or impaired individuals |
| 08/03/2006 | US20060172966 Immunostimulatory G, U-containing oligoribonucleotides |
| 08/03/2006 | US20060172960 cellular senescence and immortalization; administering a telemerase inhibitor; reduced loss of telomere length; antiproliferative agents |
| 08/03/2006 | US20060172953 Treatment of benign prostatic hyperplasia using energolytic agents |
| 08/03/2006 | US20060172937 Relates to peptides which bind to MHC molecules of either Class I or Class II; the peptides consist of amino acid sequences found in the NY-ESO-1 molecule; useful in treating cancerous conditions |
| 08/03/2006 | US20060172933 Natriuretic compounds, conjugates, and uses thereof |
| 08/03/2006 | US20060172921 Method for identifying active anti-apoptosis compounds |
| 08/03/2006 | US20060172438 Methods and kits for detecting heparin/platelet factor 4 antibodies |
| 08/03/2006 | US20060172437 Method for manufacturing a carrier for chemical or biochemical assays |
| 08/03/2006 | US20060172436 Diagnosis supporting system |
| 08/03/2006 | US20060172435 Includes two or more separated pads, and is capable of controlling the migration speed of a mobile phase between the separated pads |
| 08/03/2006 | US20060172434 Surface layer affinity-chromatography |
| 08/03/2006 | US20060172432 measuring instruments simulating the electromagnetic characteristics of a human body to measure the amount of absorption by the human body of a radio wave or waves radiated from a radio transmitter operated in the vicinity of the body through a relative scan and the radio transmitter |
| 08/03/2006 | US20060172431 Sol-gel encapsulated hexanuclear clusters for oxygen sensing by optical techniques |
| 08/03/2006 | US20060172430 Identification and characterization of protein fragments |
| 08/03/2006 | US20060172428 comprising a particle counter and a particle capture filter arranged in parallel with the particle counter; determine the presence and characteristics of particulate contaminants in the gas stream |
| 08/03/2006 | US20060172427 Method and apparatus for retrofitting existing real time control systems for monitoring, controlling, and distributing chemicals during electroplating |
| 08/03/2006 | US20060172425 Colored buffer solution for automated clinical analyzer |
| 08/03/2006 | US20060172409 Micro-reactor, dissociation constant measuring apparatus, dissociation constant measuring method, and dissociation constant measuring program |
| 08/03/2006 | US20060172404 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 08/03/2006 | US20060172380 TAB1 protein and DNA coding therefore |
| 08/03/2006 | US20060172368 CGT1 as an antifungal target |
| 08/03/2006 | US20060172365 Mass spectrometry |
| 08/03/2006 | US20060172364 Novel chromogenic substrates based on Alizarin, their applications and formulations containing such substrates |
| 08/03/2006 | US20060172362 determining homocysteine (Hcy) in samples in which homocysteine reacts with Hcy co-substrate in Hcy conversion reaction catalyzed by Hcy converting enzyme to form Hcy conversion product and Hcy co-substrate conversion product, and Hcy co-substrate conversion product is assessed to determine Hcy in sample |
| 08/03/2006 | US20060172361 Assay for detection of translocase enzyme activity in drug screening |
| 08/03/2006 | US20060172359 Identifying prions in infectious conformations in mammalian nervous system tissue; diagnosing spongiform encephalopathies in animals |
| 08/03/2006 | US20060172358 Novel chemiluminescent compounds and their use |
| 08/03/2006 | US20060172357 Detecting human antibodies in non-human serum |
| 08/03/2006 | US20060172356 include immunogenic moieties that can be used to prepare anti-lamotrigine antibodies, or antigenic moieties; antiepileptic drug, bipolar diseases; kits |
| 08/03/2006 | US20060172355 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/03/2006 | US20060172354 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/03/2006 | US20060172353 Diagnosis of candidiasis and candidemia or invasive candida infection |
| 08/03/2006 | US20060172352 Nuclear matrix proteins |
| 08/03/2006 | US20060172351 Reagent for an immunoassay |
| 08/03/2006 | US20060172350 identification and characterization of a disease and cancer-associated antigen KID24; antibodies that bind to KID24 |
| 08/03/2006 | US20060172349 LUCA2 and antibodies that bind thereto |
| 08/03/2006 | US20060172348 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 08/03/2006 | US20060172347 Method of diagnosis, treatment and useful agents for conditions characterised by modulation in the level of activin ssc |
| 08/03/2006 | US20060172346 Methods of designing and producing novel compounds having improved binding affinity for CD154 or other trimeric proteins |
| 08/03/2006 | US20060172345 Method for detecting low levels of a fusion protein |
| 08/03/2006 | US20060172344 Single chain antibody and use thereof |
| 08/03/2006 | US20060172343 Isolated using polymerase chain reaction using primers ; gene therapy; wound heaaling agents |
| 08/03/2006 | US20060172342 Antibody assay methods to assess risk for TIA/stroke |
| 08/03/2006 | US20060172341 Assay methods for immediate diagnosis of cause of stroke |
| 08/03/2006 | US20060172340 Multi-array, multi-specific electrochemiluminescence testing |
| 08/03/2006 | US20060172339 Particle-based multiplex assay for identifying glycosylation |
| 08/03/2006 | US20060172338 Detecting autoimmune and nervous system disfunction via ratio between glycans and immunoglobulin binding agent or antibodies; earlier stage dectection |
| 08/03/2006 | US20060172337 Screening molecules with anti-prion activity: kits, methods and screened molecules |
| 08/03/2006 | US20060172332 Reversibly preserved microorganism in a dormant and preserved state by in a solid, cured suspension of water and pullulan;restoration by irrigating under ambient conditions with an buffered amount of water; bacteria, yeast, and fungi; DNA;animal husbandry biosensors; integrity/quality sample; biosensor |
| 08/03/2006 | US20060172327 Sequencing of surface immobilized polymers utilizing microflourescence detection |
| 08/03/2006 | US20060172323 Identification of compounds that modify transcriptional responses to hypoxia |
| 08/03/2006 | US20060172315 Methods for staining cells for identification and sorting |
| 08/03/2006 | US20060172311 Markers for cardiac disease, sensitive and accurate; expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue; measurement of these markers, samples provides information that can correlate with diagnosis of cardiac disease |
| 08/03/2006 | US20060172310 Detection and quantification process for more than one nucleic acid in library |
| 08/03/2006 | US20060172308 Labeling reagents and labeled targets comprising nonmetallic porphyrins |
| 08/03/2006 | US20060172305 Method for determining susceptibility of tumor to treatment with anti-neoplastic agent |
| 08/03/2006 | US20060172301 Secreted acid phosphatse (sapm) is present only in pathogenic mycobacteria and expressed selectively at phagosomal ph |
| 08/03/2006 | US20060172300 Method for identifying bhs-specific proteins and fragments thereof |
| 08/03/2006 | US20060172291 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 08/03/2006 | US20060172290 Nucleic acids coding for a protein interacting with a porin channel |
| 08/03/2006 | US20060172288 methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; provides for reovirus treatment of mammals to treat proliferative disorders including breast tumors, a subset of tumors in which mutation of ras gene is not believed to play significant role |
| 08/03/2006 | US20060172281 method with which endotoxins can be removed from aqueous solutions using bacteriophage tail proteins |
| 08/03/2006 | US20060172280 System for monitoring cell motility in real-time |
| 08/03/2006 | US20060172277 Method for determining the influence of a test substance on the heart activity of a vertebrate |
| 08/03/2006 | US20060171967 Means and methods for diagnosing a treponema infection |
| 08/03/2006 | US20060171964 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 08/03/2006 | US20060171954 Antigen specific activated T-lymphocytes, detection and use |
| 08/03/2006 | US20060171953 Tumour-specific animal proteins |
| 08/03/2006 | US20060171951 Monoclonal antibodies that bind to antigen oncostatin M receptor beta subunit (OSM-R.beta); cancers |
| 08/03/2006 | US20060171931 Modulators of Wnt signalling pathways and screening methods to identify them; muscular dystrophy; inhibitors of soluble Frizzled-related proteins |
| 08/03/2006 | US20060171929 Regulation of dendritic cell functions by the DCAL-2 receptor |
| 08/03/2006 | US20060171888 Miniaturized device; substrate with reservoirs, openings; barriers layer covering aperture |
| 08/03/2006 | US20060171883 Detection, localization and staging of tumors using labeled activated lymphocytes directed to a tumor specific epitope |
| 08/03/2006 | US20060171847 Method and apparatus for analyzing mixtures of gases |
| 08/03/2006 | US20060171844 Compact aerosol concentrator for continuous use |
| 08/03/2006 | US20060170918 Detection Apparatus and Detection Method for Plasmon Resonance and Fluorescence |
| 08/03/2006 | US20060170139 Separating vessel |
| 08/03/2006 | US20060169918 Information acquistion method and apparatus for information acquistion |
| 08/03/2006 | US20060169599 Non-leachable or diffusible redox mediator; for glucose or lactate concentrations |
| 08/03/2006 | US20060169033 Fluid sensor fixture for dynamic fluid testing |
| 08/03/2006 | US20060169031 On-line monitoring of degredation and contamination of lubricant of rotating equipment |
| 08/03/2006 | DE202006008123U1 Chandler loop system for simulating blood circulation having a holder formed of several parallel compartments |
| 08/03/2006 | DE20122610U1 Apparatus to fix histological samples has a fluid extraction near the vessel heater to pass fluid through a filter and cleaned fluid is pumped back into the closed vessel, while toxic fumes are extracted |
| 08/03/2006 | DE19632862B4 Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe Immunologically active proteins of Borrelia burgdorferi, nucleic acids coding therefor and the use thereof in test kits and as vaccines |
| 08/03/2006 | DE102006003380A1 Composition e.g. hormone, test strip for a diagnostic test system, comprises a detection area coupled with a fluid sample flow path and including immobilized test and control reagents binding an analyte, and a monitoring marker respectively |
| 08/03/2006 | DE102005030035A1 Ancient stonework characterization, reconstruction and/or restoration, involves carrying out renovation and production of mortar according to measures of result of analysis of ancient stonework |
| 08/03/2006 | DE102005005528A1 Using nucleic acid to prepare injectable agent for transportation to retinal ganglion cells, useful in treatment of glaucoma and diabetic complications of the eye, acts especially by RNA intereference |